![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: DLG2 |
Gene summary for DLG2 |
![]() |
Gene information | Species | Human | Gene symbol | DLG2 | Gene ID | 1740 |
Gene name | discs large MAGUK scaffold protein 2 | |
Gene Alias | PPP1R58 | |
Cytomap | 11q14.1 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q15700 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1740 | DLG2 | HTA11_1938_2000001011 | Human | Colorectum | AD | 3.44e-02 | 1.82e-01 | -0.0811 |
1740 | DLG2 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.24e-10 | 4.45e-01 | -0.1954 |
1740 | DLG2 | HTA11_3361_2000001011 | Human | Colorectum | AD | 3.60e-07 | 4.38e-01 | -0.1207 |
1740 | DLG2 | HTA11_83_2000001011 | Human | Colorectum | SER | 3.86e-03 | 2.86e-01 | -0.1526 |
1740 | DLG2 | HTA11_696_2000001011 | Human | Colorectum | AD | 4.24e-18 | 5.60e-01 | -0.1464 |
1740 | DLG2 | HTA11_866_2000001011 | Human | Colorectum | AD | 3.85e-24 | 6.91e-01 | -0.1001 |
1740 | DLG2 | HTA11_1391_2000001011 | Human | Colorectum | AD | 4.42e-10 | 5.07e-01 | -0.059 |
1740 | DLG2 | HTA11_2992_2000001011 | Human | Colorectum | SER | 4.58e-03 | 4.94e-01 | -0.1706 |
1740 | DLG2 | HTA11_7696_3000711011 | Human | Colorectum | AD | 1.56e-05 | 8.18e-02 | 0.0674 |
1740 | DLG2 | HTA11_6818_2000001011 | Human | Colorectum | AD | 7.70e-11 | 8.35e-01 | 0.0112 |
1740 | DLG2 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 6.04e-06 | 3.67e-01 | 0.281 |
1740 | DLG2 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 2.68e-02 | 2.13e-01 | 0.3005 |
1740 | DLG2 | AEH-subject1 | Human | Endometrium | AEH | 2.52e-03 | 2.13e-01 | -0.3059 |
1740 | DLG2 | AEH-subject5 | Human | Endometrium | AEH | 1.81e-06 | 3.05e-01 | -0.2953 |
1740 | DLG2 | EEC-subject1 | Human | Endometrium | EEC | 3.26e-07 | 3.33e-01 | -0.2682 |
1740 | DLG2 | EEC-subject4 | Human | Endometrium | EEC | 2.44e-07 | 4.62e-01 | -0.2571 |
1740 | DLG2 | TD9 | Human | Lung | IAC | 7.74e-04 | 8.94e-01 | 0.088 |
1740 | DLG2 | RNA-P10T1-P10T1-2 | Human | Lung | AIS | 3.16e-04 | 1.27e+00 | -0.1028 |
1740 | DLG2 | RNA-P10T1-P10T1-4 | Human | Lung | AIS | 1.15e-03 | 1.36e+00 | -0.1173 |
1740 | DLG2 | RNA-P10T2-P10T2-1 | Human | Lung | AAH | 2.33e-12 | 1.57e+00 | -0.1271 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0009150 | Colorectum | AD | purine ribonucleotide metabolic process | 142/3918 | 368/18723 | 4.29e-15 | 1.17e-12 | 142 |
GO:0006163 | Colorectum | AD | purine nucleotide metabolic process | 149/3918 | 396/18723 | 1.08e-14 | 2.80e-12 | 149 |
GO:0072521 | Colorectum | AD | purine-containing compound metabolic process | 153/3918 | 416/18723 | 4.34e-14 | 1.01e-11 | 153 |
GO:0009259 | Colorectum | AD | ribonucleotide metabolic process | 144/3918 | 385/18723 | 5.25e-14 | 1.13e-11 | 144 |
GO:0019693 | Colorectum | AD | ribose phosphate metabolic process | 145/3918 | 396/18723 | 3.01e-13 | 5.71e-11 | 145 |
GO:0009117 | Colorectum | AD | nucleotide metabolic process | 168/3918 | 489/18723 | 2.20e-12 | 3.36e-10 | 168 |
GO:0006753 | Colorectum | AD | nucleoside phosphate metabolic process | 169/3918 | 497/18723 | 4.99e-12 | 6.98e-10 | 169 |
GO:0009135 | Colorectum | AD | purine nucleoside diphosphate metabolic process | 47/3918 | 103/18723 | 1.61e-08 | 9.22e-07 | 47 |
GO:0009179 | Colorectum | AD | purine ribonucleoside diphosphate metabolic process | 47/3918 | 103/18723 | 1.61e-08 | 9.22e-07 | 47 |
GO:0009185 | Colorectum | AD | ribonucleoside diphosphate metabolic process | 47/3918 | 106/18723 | 4.85e-08 | 2.55e-06 | 47 |
GO:0007163 | Colorectum | AD | establishment or maintenance of cell polarity | 77/3918 | 218/18723 | 5.72e-07 | 2.08e-05 | 77 |
GO:0009132 | Colorectum | AD | nucleoside diphosphate metabolic process | 49/3918 | 124/18723 | 1.75e-06 | 5.31e-05 | 49 |
GO:0045197 | Colorectum | AD | establishment or maintenance of epithelial cell apical/basal polarity | 20/3918 | 44/18723 | 2.26e-04 | 2.94e-03 | 20 |
GO:0010038 | Colorectum | AD | response to metal ion | 106/3918 | 373/18723 | 3.22e-04 | 3.83e-03 | 106 |
GO:0035088 | Colorectum | AD | establishment or maintenance of apical/basal cell polarity | 21/3918 | 49/18723 | 4.31e-04 | 4.82e-03 | 21 |
GO:0061245 | Colorectum | AD | establishment or maintenance of bipolar cell polarity | 21/3918 | 49/18723 | 4.31e-04 | 4.82e-03 | 21 |
GO:0071248 | Colorectum | AD | cellular response to metal ion | 61/3918 | 197/18723 | 5.74e-04 | 6.09e-03 | 61 |
GO:0071241 | Colorectum | AD | cellular response to inorganic substance | 68/3918 | 226/18723 | 6.98e-04 | 7.10e-03 | 68 |
GO:0009126 | Colorectum | AD | purine nucleoside monophosphate metabolic process | 19/3918 | 44/18723 | 7.13e-04 | 7.21e-03 | 19 |
GO:0030705 | Colorectum | AD | cytoskeleton-dependent intracellular transport | 60/3918 | 195/18723 | 7.56e-04 | 7.59e-03 | 60 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04530 | Colorectum | AD | Tight junction | 76/2092 | 169/8465 | 5.49e-09 | 9.69e-08 | 6.18e-08 | 76 |
hsa045301 | Colorectum | AD | Tight junction | 76/2092 | 169/8465 | 5.49e-09 | 9.69e-08 | 6.18e-08 | 76 |
hsa045302 | Colorectum | SER | Tight junction | 59/1580 | 169/8465 | 3.24e-07 | 5.98e-06 | 4.34e-06 | 59 |
hsa045303 | Colorectum | SER | Tight junction | 59/1580 | 169/8465 | 3.24e-07 | 5.98e-06 | 4.34e-06 | 59 |
hsa045304 | Colorectum | MSS | Tight junction | 66/1875 | 169/8465 | 4.10e-07 | 6.25e-06 | 3.83e-06 | 66 |
hsa04390 | Colorectum | MSS | Hippo signaling pathway | 48/1875 | 157/8465 | 8.32e-03 | 3.10e-02 | 1.90e-02 | 48 |
hsa045305 | Colorectum | MSS | Tight junction | 66/1875 | 169/8465 | 4.10e-07 | 6.25e-06 | 3.83e-06 | 66 |
hsa043901 | Colorectum | MSS | Hippo signaling pathway | 48/1875 | 157/8465 | 8.32e-03 | 3.10e-02 | 1.90e-02 | 48 |
hsa0453026 | Endometrium | AEH | Tight junction | 54/1197 | 169/8465 | 1.99e-09 | 3.80e-08 | 2.78e-08 | 54 |
hsa043909 | Endometrium | AEH | Hippo signaling pathway | 38/1197 | 157/8465 | 4.79e-04 | 3.38e-03 | 2.47e-03 | 38 |
hsa04530112 | Endometrium | AEH | Tight junction | 54/1197 | 169/8465 | 1.99e-09 | 3.80e-08 | 2.78e-08 | 54 |
hsa0439014 | Endometrium | AEH | Hippo signaling pathway | 38/1197 | 157/8465 | 4.79e-04 | 3.38e-03 | 2.47e-03 | 38 |
hsa0453027 | Endometrium | EEC | Tight junction | 54/1237 | 169/8465 | 6.56e-09 | 1.27e-07 | 9.46e-08 | 54 |
hsa0439023 | Endometrium | EEC | Hippo signaling pathway | 39/1237 | 157/8465 | 4.54e-04 | 3.47e-03 | 2.59e-03 | 39 |
hsa0453036 | Endometrium | EEC | Tight junction | 54/1237 | 169/8465 | 6.56e-09 | 1.27e-07 | 9.46e-08 | 54 |
hsa0439033 | Endometrium | EEC | Hippo signaling pathway | 39/1237 | 157/8465 | 4.54e-04 | 3.47e-03 | 2.59e-03 | 39 |
hsa051656 | Lung | IAC | Human papillomavirus infection | 71/1053 | 331/8465 | 1.88e-06 | 7.63e-05 | 5.06e-05 | 71 |
hsa0453016 | Lung | IAC | Tight junction | 43/1053 | 169/8465 | 2.44e-06 | 8.81e-05 | 5.85e-05 | 43 |
hsa043907 | Lung | IAC | Hippo signaling pathway | 35/1053 | 157/8465 | 3.60e-04 | 3.45e-03 | 2.29e-03 | 35 |
hsa0516511 | Lung | IAC | Human papillomavirus infection | 71/1053 | 331/8465 | 1.88e-06 | 7.63e-05 | 5.06e-05 | 71 |
Page: 1 2 3 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
DLG2 | SNV | Missense_Mutation | c.482N>T | p.His161Leu | p.H161L | Q15700 | protein_coding | deleterious(0.04) | probably_damaging(0.948) | TCGA-34-5929-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
DLG2 | SNV | Missense_Mutation | c.716N>A | p.Pro239Gln | p.P239Q | Q15700 | protein_coding | deleterious(0) | possibly_damaging(0.822) | TCGA-39-5019-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
DLG2 | SNV | Missense_Mutation | c.715N>A | p.Pro239Thr | p.P239T | Q15700 | protein_coding | deleterious(0.04) | benign(0.044) | TCGA-39-5019-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
DLG2 | SNV | Missense_Mutation | c.2305N>A | p.Asp769Asn | p.D769N | Q15700 | protein_coding | deleterious(0.03) | possibly_damaging(0.543) | TCGA-39-5027-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
DLG2 | SNV | Missense_Mutation | c.1789N>G | p.Gln597Glu | p.Q597E | Q15700 | protein_coding | deleterious(0.01) | benign(0.442) | TCGA-43-6770-01 | Lung | lung squamous cell carcinoma | Female | <65 | I/II | Vaccine | recprame+as15 | SD | |
DLG2 | SNV | Missense_Mutation | c.1894N>T | p.Gly632Trp | p.G632W | Q15700 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-46-3768-01 | Lung | lung squamous cell carcinoma | Male | <65 | III/IV | Chemotherapy | carboplatin | SD | |
DLG2 | SNV | Missense_Mutation | novel | c.107A>G | p.Glu36Gly | p.E36G | Q15700 | protein_coding | deleterious_low_confidence(0.03) | probably_damaging(0.969) | TCGA-56-8309-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
DLG2 | SNV | Missense_Mutation | novel | c.2260G>C | p.Glu754Gln | p.E754Q | Q15700 | protein_coding | tolerated(0.06) | benign(0.366) | TCGA-56-A4ZJ-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
DLG2 | SNV | Missense_Mutation | novel | c.2267G>C | p.Ser756Thr | p.S756T | Q15700 | protein_coding | tolerated(0.29) | benign(0.005) | TCGA-60-2715-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | docetaxel | PD |
DLG2 | SNV | Missense_Mutation | c.1713N>T | p.Gln571His | p.Q571H | Q15700 | protein_coding | deleterious(0) | possibly_damaging(0.807) | TCGA-60-2723-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |